octubre 28, 2016 2 lectura mínima

About 1 in 4 people in Swaziland are infected with HIV, so preventing mother-to-child transmission (PMTCT) is an essential strategy in reducing the country’s burden of HIV/AIDS. To achieve this however, pediatricians working in Swaziland and other low income settings underscored the need for a simple tool to enhance the dosing accuracy of liquid antiretroviral (ARV) regimens.

In response, undergraduates at [Rice 360º](http://www.rice360.rice.edu/), the prolific Institute for Global Health Technologies at Rice University, developed the [DoseRight™ Syringe Clip](http://cohesion.rice.edu/collaborations/btb/emplibrary/DoseRight%20Syringe%20Clip.pdf). These color-coded, low-cost clips are inserted into an oral dosing syringe, limiting the amount of liquid that is dispensed and dramatically increasing the likelihood of accurate dosing. Using DoseRight™, mothers can effectively administer ARVs to themselves and their children.

We’ve featured some of Rice 360º’s global health technologies in our Innovation Index, including the [salad spinner centrifuge](http://maternova.net/health-innovations/salad-spinner-centrifuge-anemia) and the [OB/GYN Lab-in-a-Backpack](http://maternova.net/health-innovations/obgyn-lab-backpack). However, what distinguishes the DoseRight™ clip is the way this technology was so rapidly deployed at the national level. In August, Swaziland’s Ministry of Health began distributing more than 200,000 dosing clips as part of its PMTCT Program.

This is the largest rollout yet of a global health technology developed by Rice 360º’s undergraduate students, who were also instrumental in securing DoseRight™’s [nationwide dissemination](http://cohesion.rice.edu/collaborations/btb/emplibrary/CGI_Poster_Final.pdf). Rice students worked for two years to build an alliance among the Swazi Ministry of Health, the [Clinton Health Access Initiative](http://www.clintonfoundation.org/what-we-do/clinton-health-access-initiative), and [3rd Stone Design](http://doseright.com/index.html), which has facilitated the distribution, funding and manufacturing of the dosing clips.

So many technologies stop at the student design stage despite extensive research and good links with a facility or Ministry in a low-income country. This is a terrific example of a full rollout that occurred quickly. Watch an [instructional video](http://doseright.com/3.html) or a video showcasing the clips on Rice 360º’s [website](http://www.rice360.rice.edu/content.aspx?id=826)!
In April, former President [Bill Clinton](http://www.media.rice.edu/media/NewsBot.asp?MODE=VIEW&ID=15599&SnID=16780591) honored Rice students for their innovation in developing the clips and their dedication in achieving its swift uptake at the national level.

Dejar un comentario

Los comentarios se aprobarán antes de mostrarse.


Ver artículo completo

Tocolytic Therapy for Improving Preterm Birth Outcome
Tocolytic Therapy for Improving Preterm Birth Outcome

octubre 05, 2022 2 lectura mínima

One of the problems that has had a strong impact on perinatal morbidity and mortality worldwide is prematurity, especially when it occurs before 34 weeks of gestation.
Ver artículo completo
Anemia in Pregnancy:  A Public Health Problem
Anemia in Pregnancy: A Public Health Problem

junio 18, 2022 3 lectura mínima

Identification of anemia in pregnant women is important, since it is an important cause of multiple complications during pregnancy (preterm delivery, low birth weight and perinatal death), so it is recommended to all pregnant women, in the first prenatal visit and at 28 weeks of gestation, the measurement of serum concentrations of hemoglobin and hematocrit as a screening test for anemia.
Ver artículo completo
Can preeclampsia be prevented?
Can preeclampsia be prevented?

junio 01, 2022 3 lectura mínima

Prenatal assessment seeks to identify, through clinical history, sociodemographic characteristics, mean blood pressure, Doppler of the uterine arteries and biochemical markers such as pregnancy-associated plasma protein A (PAPP-A) and placental growth factor (PlGF), those women who are at high risk of developing preeclampsia in order to take appropriate measures. that can help reduce that risk.
Ver artículo completo